LIVN
Livanova Plc Health Care Electromedical & Electrotherapeutic Apparatus Russell 3000
$78.97Close
$4.3BMarket cap
$49.57 – $85.3252-week range
Nov 4, 2026Next report · before the open
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Earnings growing EPS +289% year on year
Cautions
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
7%
1wk
down 2.4%
price change
1mo
up 3.2%
price change
12-month return
up 50%
market up 11% ·
its own up 37%
F-score
4 / 9
Weak
Altman Z
2.15
Moderate risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
3.6×
price / book
Earnings yield
up 5.0%
EBIT / enterprise value
Cheaper than
57%
of the market · around average
Revenue growth
up 11%
year on year
EPS growth
up 289%
latest quarter
Sales growth
up 11%
latest quarter · -4 pts
ROE
down 19%
return on equity
Free cash margin
up 12%
$173.3M FCF
D/E
0.29
long-term debt / equity
Net debt / EBITDA
-1.5×
net cash
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- profitability slipped from last year
- short-term liquidity weakened
- issued more shares
- gross margin narrowed
- generating cash from operations
- profits backed by cash
- reduced long-term debt
- assets working harder
Repair signals
- Long-term debt down 37% ($0.5B → $0.3B)
Trade setup
ATR%
2.9%
$2.25 a day · 2×ATR $74.46
RS
75 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
0.9×
vs 50-day average
Up/down volume
1.05
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Aug 5, 2026
Results reaction
Aug 5, 2026-11% vs market2 sessions after results
Financials
- Gross 68%
- Net -17%
- Free cash 12%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $934.2M | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B |
| Gross margin | 64% | 68% | 69% | 66% | 68% | 68% |
| Operating income | -$273.9M | -$784,000 | -$76.8M | -$68.5M | $129.1M | $199.4M |
| Net income | -$348.8M | -$135.8M | -$86.2M | $17.6M | $63.2M | -$242.5M |
| Net margin | -37% | -13% | -8% | 2% | 5% | -17% |
| Earnings per share | -$7.18 | -$2.68 | -$1.61 | $0.32 | $1.16 | -$4.45 |
| Free cash flow | -$114.4M | $77.1M | $43.4M | $39.9M | $135.9M | $173.3M |
| Free cash margin | -12% | 7% | 4% | 3% | 11% | 12% |
| Cash | $252.8M | $208.0M | $214.2M | $266.5M | $428.9M | $635.6M |
| Long-term debt | $642.3M | $9.8M | $518.1M | $568.5M | $549.6M | $345.2M |
| Shareholders' equity | $1.1B | $1.3B | $1.2B | $1.3B | $1.3B | $1.2B |
| Shares outstanding | 48.66m | 53.26m | 53.56m | 53.92m | 54.35m | 54.65m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| May 6, 2026 | Quarterly ↗ | Mar 31, 2026 | 36d |
| Feb 25, 2026 | Annual ↗ | Dec 31, 2025 | 56d |
| Nov 5, 2025 | Quarterly ↗ | Sep 30, 2025 | 36d |
| Aug 6, 2025 | Quarterly ↗ | Jun 30, 2025 | 37d |
| May 7, 2025 | Quarterly ↗ | Mar 31, 2025 | 37d |
| Feb 25, 2025 | Annual ↗ | Dec 31, 2024 | 56d |
| Oct 31, 2024 | Quarterly ↗ | Sep 30, 2024 | 31d |
| Aug 1, 2024 | Quarterly ↗ | Jun 30, 2024 | 32d |
| May 3, 2024 | Quarterly ↗ | Mar 31, 2024 | 33d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 1, 2023 | Quarterly ↗ | Sep 30, 2023 | 32d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 5, 2026 | Results ↗ |
| Jun 11, 2026 | Shareholder vote ↗ |
| May 6, 2026 | Results ↗ |
| Feb 25, 2026 | Results ↗ |
| Jan 14, 2026 | Director or officer change ↗ |
| Nov 5, 2025 | Results ↗ |
| Sep 4, 2025 | Director or officer change ↗ |
| Aug 6, 2025 | Results ↗ |
| Jun 11, 2025 | Director or officer change · Shareholder vote ↗ |
| May 21, 2025 | Regulation FD ↗ |
| May 7, 2025 | Results ↗ |
| Mar 17, 2025 | Regulation FD ↗ |